Meet-the-Professor Session:
198. Combination Antifungal Treatment for Mold Infections: Pros and Cons
Saturday, October 7, 2017: 7:00 AM-8:15 AM
Room: 11AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the antifungal drug options for combination treatment against molds
  • review the evidence in favor or against the use of combination antifungal therapy against mold infections

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Medical students and residents, Members-in-training, Microbiologists, Pharmacists, Researchers, Scientists

Tracks: Trainee, Pediatric ID, Global ID, Adult ID


Moderator:  Michail Lionakis, MD, ScD, NIH

Presentations:
7:00 AM
Combination Antifungal Treatment for Mold Infections: Pros
Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), FACP, FIDSA, FECMM, FAAM

8:00 AM
Q&A

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-290-L01-P

Disclosures:

M. Lionakis, Viamet Inc: Grant recipient , Grant recipient
Matinas BioPharma: Grant recipient , Research grant

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.